Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis

F. De Benedetti, M. Massa, P. Pignatti, M. Kelley, C. R. Faltynek, A. Martini

Research output: Contribution to journalArticlepeer-review


Objective. Since interleukin-7 (IL-7) has been shown to induce monocyte production of IL-1, IL-6, IL-8, and tumor necrosis factor-α, we investigated plasma and synovial fluid levels of IL-7 in patients with juvenile rheumatoid arthritis (JRA). Methods. IL-7 levels were measured using an ELISA in 60 patients with JRA and in 25 patients with other rheumatic disorders (ORD). Results. In patients with systemic JRA, but not in patients with polyarticular or pauciarticular JRA or with ORD, plasma IL-7 levels were significantly higher (p <0.0001) than those of healthy controls. IL-7 was undetected in all synovial fluid tested. Among patients with systemic JRA, those with persistent systemic symptoms had IL-7 levels significantly higher (p <0.01) than those of patients in which systemic symptoms subsided. Conclusion. Plasma IL-7 levels are elevated in patients with systemic JRA and are associated with the presence and severity of systemic symptoms.

Original languageEnglish
Pages (from-to)1581-1585
Number of pages5
JournalJournal of Rheumatology
Issue number8
Publication statusPublished - 1995


  • Interleukin-7
  • Systemic juvenile rheumatoid arthritis

ASJC Scopus subject areas

  • Immunology
  • Rheumatology


Dive into the research topics of 'Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this